4//SEC Filing
HAMED KAMAL 4
Accession 0000899243-23-003942
CIK 0001701108other
Filed
Feb 2, 7:00 PM ET
Accepted
Feb 3, 7:40 PM ET
Size
5.2 KB
Accession
0000899243-23-003942
Insider Transaction Report
Form 4
HAMED KAMAL
Chief Medical Officer
Transactions
- Award
Common Stock
2023-02-01+265,957→ 475,957 total
Footnotes (2)
- [F1]Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock upon vesting. The RSUs vest in four equal annual installments beginning on February 1, 2024, subject to the Reporting Person's continued service through the applicable vesting date.
- [F2]Includes 475,957 RSUs held by the Reporting Person.
Documents
Issuer
Spero Therapeutics, Inc.
CIK 0001701108
Entity typeother
Related Parties
1- filerCIK 0001946366
Filing Metadata
- Form type
- 4
- Filed
- Feb 2, 7:00 PM ET
- Accepted
- Feb 3, 7:40 PM ET
- Size
- 5.2 KB